A Brief Review of the Effects of Vitamin D on Multiple Sclerosis.

Miclea, Andrei; Bagnoud, Maud; Chan, Andrew; Hoepner, Robert (2020). A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Frontiers in immunology, 11(781), p. 781. Frontiers Research Foundation 10.3389/fimmu.2020.00781

[img]
Preview
Text
Miclea, 2020, Brief Review of the Effects of Vitamin D on MS.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (483kB) | Preview

Multiple sclerosis (MS) is characterized as an autoimmune disease affecting the central nervous system. It is one of the most common neurological disorders in young adults. Over the past decades, increasing evidence suggested that hypovitaminosis D is a contributing factor to the risk of developing MS. From different risk factors contributing to the development of MS, vitamin D status is of particular interest since it is not only a modifiable risk factor but is also associated with MS disease activity. MS patients with lower serum vitamin D concentrations were shown to have higher disease activity. However, this finding does not demonstrate causality. In this regard, prospective vitamin D supplementation studies missed statistical significance in its primary endpoints but showed promising results in secondary outcome measures or post hoc analyses. An explanation for missed primary endpoints may be underpowered trials. Besides vitamin D supplementation as a potential add-on to long-term immunotherapeutic treatment, a recent laboratory study of our group pointed toward a beneficial effect of vitamin D to improve the efficacy of glucocorticoids in relapse therapy. In the following article, we will briefly review the effects of vitamin D on MS by outlining its effects on the immune and nervous system and by reviewing the association between vitamin D and MS risk as well as MS disease activity. We will also review the effects of vitamin D supplementation on MS risk and MS disease activity.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Miclea, Andrei; Bagnoud, Maud Marie; Chan, Andrew Hao-Kuang and Hoepner, Robert

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1664-3224

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

Chantal Kottler

Date Deposited:

03 Nov 2020 17:25

Last Modified:

16 Mar 2021 17:02

Publisher DOI:

10.3389/fimmu.2020.00781

PubMed ID:

32435244

Uncontrolled Keywords:

MS risk calcitriol cholecalciferol disease activity guidelines innate adaptive immune system metabolism nervous system

BORIS DOI:

10.7892/boris.147340

URI:

https://boris.unibe.ch/id/eprint/147340

Actions (login required)

Edit item Edit item
Provide Feedback